A case series study has determined that it is safe to use the multiple sclerosis medication Lemtrada (alemtuzumab) during the COVID-19 pandemic.
The study was...
Tag - lemtrada
The multiple sclerosis medication Lemtrada (alemtuzumab) may cause severe ANCA-associated vasculitis, according to a study published in February.
The study’s...
Sanofi-Aventis U.S., LLC recently agreed to pay $11.85 million to resolve allegations of Lemtrada kickbacks which violated the False Claims Act.
Sanofi paid...